| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P356 | DOI | 10.1007/S13277-013-1123-2 |
| P698 | PubMed publication ID | 23982879 |
| P2093 | author name string | Weichang Chen | |
| Nan Gao | |||
| Mei Han | |||
| Wenyan Tian | |||
| Dong-Tao Shi | |||
| P2860 | cites work | Quantitative assessment of gene methylation and their impact on clinical outcome in gastric cancer. | Q54326919 |
| Aberrant CpG island hypermethylation of RASSF1A in gastric cardia adenocarcinoma. | Q54497761 | ||
| The epidemiology of gastric cancer | Q57586419 | ||
| [The influence of promoter methylation of RASSF1A on RASSF1A mRNA and protein expression in gastric cancer tissues]. | Q64960281 | ||
| DNA methylation and cancer | Q81002014 | ||
| Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3 | Q81393841 | ||
| Global cancer statistics | Q22241238 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Meta-analysis in clinical trials | Q27860779 | ||
| Statistical aspects of the analysis of data from retrospective studies of disease | Q27860916 | ||
| Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. | Q30884723 | ||
| Association of diminished expression of RASSF1A with promoter methylation in primary gastric cancer from patients of central China | Q33289807 | ||
| Genetic and epigenetic changes in stomach cancer | Q34177743 | ||
| Clinical potential of DNA methylation in gastric cancer: a meta-analysis | Q34257393 | ||
| The prognostic role of RASSF1A promoter methylation in breast cancer: a meta-analysis of published data | Q34277400 | ||
| The association of RAS association domain family Protein1A (RASSF1A) methylation states and bladder cancer risk: a systematic review and meta-analysis | Q34471940 | ||
| Genetic and epigenetic alterations of tumor suppressor and tumor-related genes in gastric cancer | Q34507632 | ||
| Epidemiology of Helicobacter pylori and gastric cancer | Q34647538 | ||
| Polymorphism of A133S and promoter hypermethylation in Ras association domain family 1A gene (RASSF1A) is associated with risk of esophageal and gastric cardia cancers in Chinese population from high incidence area in northern China | Q34738516 | ||
| Methylation of the RASSF1A gene in human cancers | Q34835468 | ||
| Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions | Q34998563 | ||
| Gastric cancer epidemiology and risk factors | Q35067625 | ||
| Meta-analysis: State-of-the-Science | Q35188900 | ||
| The tumor suppressor RASSF1A in human carcinogenesis: an update | Q36056924 | ||
| Role of the Ras-association domain family 1 tumor suppressor gene in human cancers | Q36113844 | ||
| DNA methylation and gene silencing in cancer | Q36338042 | ||
| The role of RASSF1A methylation in cancer | Q36746212 | ||
| Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients | Q37265620 | ||
| The prognostic value of RASSF1A promoter hypermethylation in non-small cell lung carcinoma: a systematic review and meta-analysis | Q37820803 | ||
| Epigenetic mechanisms in gastric cancer | Q38018086 | ||
| Epigenetic inactivation of RASSF1A in head and neck cancer | Q40632129 | ||
| Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). | Q43565569 | ||
| Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma. | Q43755869 | ||
| Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. | Q44226862 | ||
| Summing up evidence: one answer is not always enough. | Q52900179 | ||
| Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis. | Q53379613 | ||
| Profile of aberrant CpG island methylation along multistep gastric carcinogenesis. | Q53864201 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 943-948 | |
| P577 | publication date | 2013-08-28 | |
| P1433 | published in | Tumor Biology | Q15757842 |
| P1476 | title | Association of RASSF1A promoter methylation with gastric cancer risk: a meta-analysis | |
| P478 | volume | 35 |
| Q37001109 | Aberrant methylation of PCDH10 and RASSF1A genes in blood samples for non-invasive diagnosis and prognostic assessment of gastric cancer |
| Q55499618 | Aerobic exercise and DNA methylation in postmenopausal women: An ancillary analysis of the Alberta Physical Activity and Breast Cancer Prevention (ALPHA) Trial. |
| Q35909621 | Clinical utility of RASSF1A methylation in human malignancies |
| Q47146471 | Promoter methylation of tumor-related genes as a potential biomarker using blood samples for gastric cancer detection |
| Q37585495 | RASSF1A promoter methylation is associated with increased risk of thyroid cancer: a meta-analysis |
| Q36143417 | Salivary DNA methylation panel to diagnose HPV-positive and HPV-negative head and neck cancers |
| Q58734058 | The FENDRR/miR-214-3P/TET2 axis affects cell malignant activity via RASSF1A methylation in gastric cancer |
Search more.